Decline depth
-24.4%
From rolling 252-day high of $101.40, 281d ago.
Past the 20% Watch threshold.
-24.4%
from rolling 252-day high of $101.40 set 2026-01-08 · 281d ago
Current
$76.71
Decline depth
-24.4%
Decline σ
2.7σ
TFC
2/5 bearish
Where it stands
On the Watch.
Down 24.4% from its rolling 252-day high, 281 days after the high.
Snapshot . Price structure, not a judgment about the business.
A bullish structural signal is also active. The Recovering badge coexists with the decline tier; it does not establish a completed recovery.
What changed
Since the previous observation.
Tier and recovery signal are unchanged between these two observations.
Comparing with . This compares classification, not price returns.
See the recorded timeline →Why it is flagged
GMED qualifies for the Watch on decline depth.
Down 24.4% from its rolling 252-day high, 281 days after the high. The most severe triggered rule determines the tier.
Inspect the three classification measures
Time-frame continuity
2/5 bearish
Latest bar on five time frames, daily to yearly. Bearish = 2-Down or red 3.
Decline sigma
2.7σ
Drop over the last 5 bars in units of daily volatility (1.62%/day).
Price history
The price path behind the snapshot.
Daily prices with the rolling-high reference. When a recorded classification event falls on a displayed trading date, it is marked on the chart.
Rolling 252-day high
Gold dots: recorded classification events (see timeline)
Up day
Down day
90 daily bars from Alpaca · through
The recorded history
A timeline of observations.
First observed 2026-05-15. These are scan observations, not exact transition times or the start of a decline. Missing scan dates are not filled in.
- Amber List; recovery signal active → Watch; recovery signal active
- Red List; recovery signal active → Amber List; recovery signal active
- Red List → Red List; recovery signal active
- Red List; recovery signal active → Red List
- Red List → Red List; recovery signal active
- Red List; recovery signal active → Red List
- Red List → Red List; recovery signal active
- Amber List → Red List
- Watch → Amber List
- Watch; recovery signal active → Watch
- Unmatched; coverage or recovery unconfirmed → Watch; recovery signal active
- Watch; recovery signal active → Unmatched; coverage or recovery unconfirmed
Showing the latest 12 of 35 recorded events.
Absence from a captured list does not establish recovery. Historical tiers reflect the rules and data recorded at that time.
Technical interpretation and signal details
The structural read
What price action says about GMED.
GMED qualifies for the Watch on decline depth — down -24.4% from its rolling 252-day high.
A confirmed bullish signal on one or more time frames earned the Recovering badge. The tier reflects the most severe price-structure rule; Recovering identifies a separate bullish signal. Not a buy signal.
Whether GMED's turn is investable is ConvictionEdge's question, not ours.
Upstream TFC read: moderate alignment, current phase weekly. Last bar types — daily 3 (red), weekly 2U (green), monthly 2D (green).
Earnings on file: 2026-08-06. Earnings dates don't affect tiering.
Questions about GMED
What people ask.
Why is GMED on Broken Stocks?
GMED qualifies for the Watch on decline depth. It is down -24.4% from its rolling 252-day high of $101.40, set on 2026-01-08 — 281d ago. It additionally carries a Recovering badge — see below.
What does the Recovering badge mean for GMED?
Recovering means our proprietary engine has flagged a confirmed bullish structural signal on one or more time frames (moderate or strong time-frame continuity). It coexists with the decline tier — GMED is still Watch because a price-structure rule still triggers, but a bullish setup has formed inside that decline. The two readings answer different questions: the tier reflects the most severe triggered rule; the Recovering badge tells you whether momentum may be turning. It's not a buy recommendation.
Is GMED a falling knife?
No. The falling-knife label usually implies a steep, severe drop — typically 30% or more from a fresh high. GMED is down -24.4% from its 52-week high, which qualifies for the Watch tier but is shallower than the falling-knife pattern. It's an early-stage decline rather than a sharp breakdown.
Is GMED a buy?
Broken Stocks does not issue buy or sell recommendations. The list is a rules-based technical warning system. It tracks structural decline depth and recency — not company quality, management, fundamentals, or news. Always do your own research and consult a licensed advisor.
Where is GMED trading inside its 52-week range?
At $76.71, GMED sits 47.7% of the way from its 52-week low ($54.15) to its 52-week high ($101.40). A reading below 25% indicates price is hugging the bottom of the range; above 75%, the top.
How fast has GMED been declining?
The current 24.4% decline accrued over 281d, which annualizes to roughly -31.7% per year. Annualized pace is a sanity check — a 30% decline in three months is a different signal than a 30% decline over two years.
How does GMED compare to its sector?
There are 408 other Healthcare tickers on Broken Stocks: 274 Red, 95 Amber, 39 Watch, with 177 showing recovering structural signals. Median sector decline is -37.5% — GMED's decline is shallower than the sector median.
Does GMED's earnings date affect its tier?
No. Tiering uses decline depth and recency, bearish time-frame structure, and decline sigma. The earnings date on file (2026-08-06) is shown for reference only — listings can move tier between scans based on closing prices, regardless of fundamentals or news events.